Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice

Journal of Infectious Diseases

Volumn 190, Issue 3, 2004, Pages 624-631

  Huang, Weitao ^a   Na, Li ^a   Fidel, Paul L ^a   Schwarzenberger, Paul ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN RECEPTOR; PROTEIN SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL MOTILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EVALUATION; HOST RESISTANCE; IN VIVO STUDY; KIDNEY; LETHALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROVOCATION TEST; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SYSTEMIC DISEASE; TIME;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-17; KIDNEY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-17; RECOMBINANT PROTEINS;

EID: 3242814586     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/422329     Document Type: Article

References (30)

1. Bodey GP, Mardani M, Hanna HA, et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med 2002; 112:380-2.
2. McNeil MM, Nash SL, Hajjeh RA, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001; 33:641-2.
3. Martino P, Girmenia C, Micozzi A, De Bernardis F, Boccanera M, Cassone A. Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients. Eur J Clin Microbiol Infect Dis 1994; 13:797-804.
4. Laverdiere M, Rotstein C, Bow EJ, et al. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study. J Antimicrob Chemother 2000; 46:1001-2.
5. Chang HY, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ. Causes of death in adults with acute leukemia. Medicine (Baltimore) 1976; 55:259-28.
6. Morrison VA. The infectious complications of chronic lymphocytic leukemia. Semin Oncol 1998; 25:98-206.
7. Schwarzenberger P, La Russa V, Miller A, et al. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol 1998; 161:6383-9.
8. Ye P, Garvey P, Zhang P, et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 2001; 25:335-40.
9. Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194:519-27.
10. + cells in acute, systemic murine candidosis. J Leukoc Biol 1992; 51:305-6.
11. Fulurija A, Ashman RB, Papadimitriou JM. Increased tissue resistance in the nude mouse against Candida albicans without altering strain-dependent differences in susceptibility. J Med Vet Mycol 1997; 35:197-203.
12. Mencacci A, Perruccio K, Bacci A, et al. Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. Blood 2001; 97:1483-90.
13. Tavares D, Ferreira P, Arala-Chaves M. Increased resistance to systemic candidiasis in athymic or interleukin-10-depleted mice. J Infect Dis 2000; 182:266-73.
14. Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol 2002; 71:1-2.
15. Schwarzenberger P, Huang W, Ye P, et al. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol 2000; 164:4783-9.
16. Schwarzenberger P, Huang W, Oliver P, Osidipe T, Theodossiou C, Kolls JK. Poly-L-lysine-based molecular conjugate vectors: a high efficiency gene transfer system for human progenitor and leukemia cells. Am J Med Sci 2001; 321:129-36.
17. Williams FM, Kus M, Tanda K, Williams TJ. Effect of duration of ischaemia on reduction of myocardial infarct size by inhibition of neutrophil accumulation using an anti-CD18 monoclonal antibody. Br J Pharmacol 1994; 111:1123-8.
18. Layton JE, Hockman H, Sheridan WP, Morstyn G. Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor. Blood 1989; 74:1303-7.
19. Hubel K, Dale DC, Liles WC. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-γ. J Infect Dis 2002; 185:1490-501.
20. Sherry B, Cerami A. Small cytokine superfamily. Curr Opin Immunol 1991; 3:56-60.
21. Miyake T, Takeya K, Nomoto K, Muraoka S. Cellular elements in the resistance to Candida infection in mice. I. Contribution of T lymphocytes and phagocytes at various stages of infection. Microbiol Immunol 1977; 21:703-25.
22. Cantorna MT, Balish E. Acquired immunity to systemic candidiasis in immunodeficient mice. J Infect Dis 1991; 164:936-43.
23. + T cells are involved in elimination of Candida albicans from the livers of mice. Mycoses 1997; 40:41-2.
24. Han Y, Cutler JE. Antibody response that protects against disseminated candidiasis. Infect Immun 1995; 63:2714-9.
25. Garbino J, Kolarova L, Lew D, Hirschel B, Rohner P. Fungemia in HIV-infected patients: a 12-year study in a tertiary care hospital. AIDS Patient Care STDS 2001; 15:407-20.
26. Whimbey E, Gold JW, Polsky B, et al. Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104:511-2.
27. + cells also demonstrate strain-specific immunopathological effects. Microbiology 1999; 145:1631-40.
28. Kullberg BJ, Netea MG, Curfs JHAJ, Keuter M, Meis JFGM, Van der Meer JWM. Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice. J Infect Dis 1998; 177:175-81.
29. Hamood M, Bluche P, De Vroey C, Corazza F, Bujan W, Fondu P. Effects of recombinant human granulocyte-colony stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti-C. albicans resistance. Mycoses 1994; 37:93-9.
30. Basu S, Hodgson G, Zhang HH, Katz M, Quilici C, Dunn AR. "Emergency" granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Blood 2000; 95:3725-33.